“In order to improve the system of drug provision for patients with diabetes mellitus it is important to increase competition on the insulin market,” said ARPM Director General, Victor Dmitriev after the conference on “Improvement of legislation of treatment and prevention of diabetes mellitus in Russia”, which was hold in the State Duma. The conference was organized by the healthcare committee was attended by legislative and executive authorities, as well as local medical producers, professional and public organizations. “A guarantee provision of patients with diabetes mellitus is not only a healthcare issues, but also an issues of an economic and sociopolitical matter. Implementation of the PHARMA 2020 strategy helped to create a number of production facilities, which are able to provide with aniti- diabetic medication. We can support those factories in order to increase their export potentials,” said Mr. Dmitriev. Chairmen of the Duma committee on healthcare, Sergey Fugal noted that diabetes mellitus is one of the leading socio-medical problems of the society. The number of affected people has increased in the past years. According to the WHO there are over 9 million patients with diabetes mellitus. Deputy of Director of the department of pharmaceutical and medical production of the Ministry of Trade and Industry, Dmitry Kolobov spoke on the current conditions and future of the Russia’s market of insulins, as well as on the role of pharmaceutical companies in the fight against the disease. According to Mr. Kilobov, the total value of the market riches 11 billion Rubles in 2014. The share of domestically produced medicines was only 7% monetary in the first half of 2015. He also noted the increasing number of domestic and foreign companies that localized in Russia and are producing insulines. Among the domestic companies he methane “Medisnthes”, “Geropharm”, “Pharmstandard” and others. The Ministry also supports R&D in the areas of anti- diabetic medicines. Healthcare Ministry representative, Tareza Kasaeva spoke on the existing measures to that diabetes mellitus. A Federal Register of diabetic patients has been developed and introduced together with the legislation that provides access to medical services for patients. Also, the work on improvement of medical facilities is being hold. Director of the Institute of Pediatric Endocrinology, Valentina Peterkova said that in order to successfully fight the disease it is important to fix issues of lack of personnel, diagnostic of the disease on the late stages, as well as other measures of state support.“In order to improve the system of drug provision for patients with diabetes mellitus it is important to increase competition on the insulin market,” said ARPM Director General, Victor Dmitriev after the conference on “Improvement of legislation of treatment and prevention of diabetes mellitus in Russia”, which was hold in the State Duma. The conference was organized by the healthcare committee was attended by legislative and executive authorities, as well as local medical producers, professional and public organizations.

“A guarantee provision of patients with diabetes mellitus is not only a healthcare issues, but also an issues of an economic and sociopolitical matter. Implementation of the PHARMA 2020 strategy helped to create a number of production facilities, which are able to provide with aniti- diabetic medication. We can support those factories in order to increase their export potentials,” said Mr. Dmitriev.

Chairmen of the Duma committee on healthcare, Sergey Fugal noted that diabetes mellitus is one of the leading socio-medical problems of the society. The number of affected people has increased in the past years. According to the WHO there are over 9 million patients with diabetes mellitus.

Deputy of Director of the department of pharmaceutical and medical production of the Ministry of Trade and Industry, Dmitry Kolobov spoke on the current conditions and future of the Russia’s market of insulins, as well as on the role of pharmaceutical companies in the fight against the disease. According to Mr. Kilobov, the total value of the market riches 11 billion Rubles in 2014. The share of domestically produced medicines was only 7% monetary in the first half of 2015. He also noted the increasing number of domestic and foreign companies that localized in Russia and are producing insulines. Among the domestic companies he methane “Medisnthes”, “Geropharm”, “Pharmstandard” and others. The Ministry also supports R&D in the areas of anti- diabetic medicines.

Healthcare Ministry representative, Tareza Kasaeva spoke on the existing measures to that diabetes mellitus. A Federal Register of diabetic patients has been developed and introduced together with  the legislation that provides access to medical services for patients. Also, the work on improvement of medical facilities is being hold.

Director of the Institute of Pediatric Endocrinology, Valentina Peterkova said that in order to successfully fight the disease it is important to fix issues of lack of personnel, diagnostic of the disease on the late stages, as well as other measures of state support.